Rivka Carmi

She served as President of Ben-Gurion University of the Negev (BGU) from May 2006 - December 2018. She succeeded Avishay Braverman, and was followed by Daniel Chamovitz.

In February 2018, the executive committee announced that a new president would be elected by the end of year.

In November 2017, the search committee for president recommended extending Carmi's tenure as president by two additional years, through May 2020. In response, the academic senate held an extraordinary meeting, in which it declared that the search committee failed and called for the resignation of the chair of the executive committee, Asher Heled. The executive committee decided to approve the extension despite the objections of the academic staff, which resulted in further protest. The State Comptroller of Israel launched an investigation into the selection process. In response, Carmi stated: "What I have in mind is the good of the university, so once a person is elected to head it, I will be the first to congratulate, to vacate my place and to pave the way for anyone found to be suitable - even if it is earlier than the two years that I was asked to fill.

In May 2014 Carmi was appointed to the Locker Committee which examined Israel's national defense budget. In 2011 she was appointed chairperson of the Promotion and Representation of Women in Higher Education Institutions Committee (the Carmi Team). In 2015 she headed the task force of the Israeli Medical Association established to study the status of women in medicine.

Carmi is a member of the Advisory Board of the Genesis Prize Foundation. She is a founding member of the UK-Israel Science Council and served as its co-chair alongside Professor Raymond Dwek in the years 2010-2017. On April 4, 2013, the Minister of Justice, MP Tzipi Livni, appointed Carmi to be part of the Rivlin Committee. The committee examined the compensation agreement for workers of the nuclear research facility in Dimona that were exposed to ionizing radiation and diagnosed with cancer.

Carmi’s research focused mainly on the delineation of the clinical manifestations and molecular basis of genetic diseases in the Negev Arab-Bedouin population. Author of over 150 publications in medical genetics, her research included the identification of 12 new genes and the delineation of 2 new syndromes, one of which is known as the Carmi Syndrome. Carmi's first academic publication (1977) described an accumulation of carbon dioxide oxygen hoods, infant cots and incubators in possible relation with the sudden infant death syndrome phenomenon. Her community outreach projects were aimed at preventing hereditary diseases and advancing women's education in the Bedouin community. She was involved with the establishment of biotechnology initiatives at Ben-Gurion University of the Negev, and served as the Acting Director of the nascent National Institute for Biotechnology in the Negev.

Rivka Carmi (Hebrew: רבקה כרמי; born 1948) is an Israeli pediatrician and geneticist. She served as President of Ben-Gurion University of the Negev (BGU) from May 2006 until December 2018. Carmi is the first woman to be appointed president of an Israeli university.